CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics

CTT Pharma (OTCQB:CTTH) announced on December 16, 2025 that a peer‑reviewed paper was published in the journal Drug Delivery and Therapeutics by Dr. Katharine Cole and Dr. Pankaj Modi.

Rhea-AI Summary

CTT Pharma (OTCQB:CTTH) announced on December 16, 2025 that a peer‑reviewed paper was published in the journal Drug Delivery and Therapeutics by Dr. Katharine Cole and Dr. Pankaj Modi.

The review describes how micellar nanotechnology combined with an oral dissolvable strip delivery system can improve delivery and bioavailability of active therapeutic compounds. The company says the article is the first comprehensive scientific review on this combined approach.

The publication is available in the company's Scientific Publications section at www.cttpharmaceuticals.com and the company indicates additional peer‑reviewed articles will be added as available.

Argus Dec 16 session

+6.91% close to close Open Argus

Details

News Market Reaction – CTTH

On Dec 16, the day this news came out, CTTH closed 6.91% above the previous close.

Data tracked by StockTitan Argus for the Dec 16 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

TAMPA, FL / ACCESS Newswire / December 16, 2025 / (OTCQB:CTTH) CTT Pharmaceutical Holdings, Inc. is pleased to announce that a peer-reviewed scientific paper has been published in the journal of Drug Delivery and Therapeutics, authored by our scientist Dr. Katharine Cole and Dr. Pankaj Modi, the founder of CTT Pharma. The article provides the first comprehensive scientific review describing how micellar nanotechnology, when combined with an oral dissolvable strip delivery system, can significantly improve the delivery and bioavailability of active therapeutic compounds. "This review article is an important step forward in bringing wider scientific attention to this innovative and transformative technology," said Dr. Cole.

This publication is available on the Company's website www.cttpharmaceuticals.com in the 'Scientific Publications' section. This section includes peer-reviewed articles authored by CTT scientists that contribute to the broader scientific literature in areas relevant to the company's scientific focus. These publications are provided solely for transparency and informational purposes. Additional publications will be added as they become available.

CTT Pharma
813-606-0060

SOURCE: CTT Pharmaceutical Holdings, Inc.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CTTH publish on December 16, 2025?

CTT Pharma published a peer‑reviewed review in Drug Delivery and Therapeutics by Dr. Katharine Cole and Dr. Pankaj Modi.

Where can investors read the CTTH peer‑reviewed paper published December 16, 2025?

The paper is posted in the Scientific Publications section at www.cttpharmaceuticals.com.

What is the paper's main finding about micellar nanotechnology and oral dissolvable strips?

The review explains that combining micellar nanotechnology with an oral dissolvable strip can improve drug delivery and bioavailability.

Who authored the CTTH December 2025 publication?

The authors are Dr. Katharine Cole and Dr. Pankaj Modi, founder of CTT Pharma.

Will CTT Pharma publish more peer‑reviewed articles on its website?

The company says additional peer‑reviewed publications will be added to the Scientific Publications section as they become available.